Lei Luo
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Health Informatics top 10%
Papers in
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
- Oncology 10
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Xiaolan Tang (6 shared papers)Guiming Zhang (10 shared papers)Ming-Fang Wang (2 shared papers)Ganghua Tang (2 shared papers)Bin Li (4 shared papers)Fangning Wan (2 shared papers)Lijiang Sun (8 shared papers)Hanwei Huang (3 shared papers)
- Journals
- OncoTargets and Therapy (4 papers)Nuclear Medicine and Biology (3 papers)Scientific Reports (3 papers)Medicine (2 papers)Tumor Biology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Lei Luo
49 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 187
- Health Informatics 19
- Oncology 217
- Pulmonary and Respiratory Medicine 193
- Radiology, Nuclear Medicine and Imaging 136
Countries citing papers authored by Lei Luo
This map shows the geographic impact of Lei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Luo more than expected).
Fields of papers citing papers by Lei Luo
This network shows the impact of papers produced by Lei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Luo. The network helps show where Lei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 137 | |
| 2 | 2022 | 96 | |
| 3 | 2015 | 83 | |
| 4 | 2005 | 72 | |
| 5 | 2019 | 54 | |
| 6 | 2018 | 50 | |
| 7 | 2018 | 40 | |
| 8 | 2019 | 34 | |
| 9 | 2019 | 31 | |
| 10 | 2003 | 29 | |
| 11 | 2022 | 29 | |
| 12 | 2003 | 26 | |
| 13 | 2016 | 25 | |
| 14 | 2024 | 21 | |
| 15 | 2015 | 20 | |
| 16 | 2018 | 18 | |
| 17 | 2016 | 18 | |
| 18 | 2017 | 17 | |
| 19 | 2019 | 16 | |
| 20 | 2021 | 16 |
About Lei Luo
Lei Luo is a scholar working on Cancer Research, Oncology, Biochemistry, Pulmonary and Respiratory Medicine and Surgery, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Medical Imaging Techniques and Applications (5 papers), MicroRNA in disease regulation (5 papers), Amino Acid Enzymes and Metabolism (4 papers), Cancer-related molecular mechanisms research (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Surgical Simulation and Training (3 papers). The work is most often cited by research in Cancer Research (187 citations), Health Informatics (19 citations), Oncology (217 citations), Pulmonary and Respiratory Medicine (193 citations) and Radiology, Nuclear Medicine and Imaging (136 citations). Lei Luo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xiaolan Tang, Guiming Zhang, Ming-Fang Wang, Ganghua Tang, Bin Li, Fangning Wan, Lijiang Sun, Hanwei Huang, Ganghua Tang and Pengliang Wang. Their work appears in journals such as OncoTargets and Therapy, Nuclear Medicine and Biology, Scientific Reports, Medicine and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.